CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The...
Cleveland, Ohio, United States and 3 other locations
the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects with Metastatic Pancreatic...
Phase 1
Cleveland, Ohio, United States and 7 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Cleveland, Ohio, United States and 108 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...
Phase 1
Cleveland, Ohio, United States and 76 other locations
The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at deli...
Cleveland, Ohio, United States and 1 other location
This is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as wel...
Phase 1
Cleveland, Ohio, United States and 15 other locations
to higher doses of ARV-806. Adults with advanced cancers having a specific KRAS mutation will be included.In Part B (Phase 2), participants...
Phase 1, Phase 2
Cleveland, Ohio, United States and 13 other locations
The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the s...
Phase 1, Phase 2
Cleveland, Ohio, United States and 12 other locations
of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic...
Phase 3
Cleveland, Ohio, United States and 227 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Cleveland, Ohio, United States and 118 other locations
Clinical trials
Research sites
Resources
Legal